In prostate cancers, SYNPO2 exhibits dual functions in regulating tumor progression, with some reports showing that its C terminal region inhibits cancer invasion and metastasis while others support the notion that some isoforms of SYNPO2 increase chemokinetic properties and promotes migration [9, 10]. This evidence concerns the gene SYNPO2 and neoplasm.